InvestorsHub Logo
Followers 11
Posts 1455
Boards Moderated 0
Alias Born 02/01/2013

Re: None

Thursday, 11/17/2016 10:45:30 AM

Thursday, November 17, 2016 10:45:30 AM

Post# of 10476
Technical Reports on Healthcare Equities -- Organovo, ---
BY PR Newswire
— 6:00 AM ET 11/16/2016
NEW YORK, November 16, 2016 /PRNewswire/ --

On Tuesday, shares in California headquartered Organovo Holdings Inc. ( ONVO ) recorded a trading volume of 717,654 shares. The stock ended the day at $3.30, rising 0.61%. The Company's shares have gained 32.53% on an YTD basis. The stock is trading above its 200-day moving average by 4.95%. Furthermore, shares of Organovo Holdings ( ONVO), which focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs, have a Relative Strength Index (RSI) of 54.93.
On November 03rd, 2016, Organovo ( ONVO ) reported Q2 FY17 total revenue of $1.4 million, which increased 358% versus Q2 FY16. The Company ended Q2 FY17 with cash and cash equivalents balance of $51.7 million. Organovo's ( ONVO ) net cash utilization during the period was $6.8 million.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News